GILD vs ORGO · P/E 18, rev $7.80B vs rev $81.0M
Gilead Sciences Inc (GILD) versus Organogenesis Holdings Inc (ORGO) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. ORGO currently screens at market cap $301.1M.
Not investment advice. Open the GILD and ORGO stock pages for the full models.
Not investment advice.